🟢 Aspire BioPharma is trading 5% up in after-hours trading with no clear catalyst identified

Aspire BioPharma is trading 5% higher at $8.61 in after-hours trading, with no clear catalyst identified.

• Shares closed at $8.20 on September 22, 2026.
• No credible company-specific announcement, filing, earnings release, or other catalyst dated September 22 was identified.
• The September 8 name change and September 9 share-repurchase authorization predate the move. Broader markets were mixed, so the reason remains uncertain.